收藏切换
Global progress in peptide radiopharmaceutical research and China's opportunities
收藏切换
PDF
Xue-yao CHEN, Bo-yang ZHANG, Kuan HU*, Rui WANG*
Acta Pharmaceutica Sinica | 2023, 58(12) : 3477 - 3489
Less
收藏切换
Acta Pharmaceutica Sinica | 2023, 58(12): 3477-3489
Global progress in peptide radiopharmaceutical research and China's opportunities
Full
Xue-yao CHEN, Bo-yang ZHANG, Kuan HU*, Rui WANG*
Affiliations
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2023-12-12 doi: 10.16438/j.0513-4870.2023-1193
Outline
收藏切换

Radiopharmaceutical is an essential component of nuclear medicine and molecular imaging, as well as a key component of precision medicine. The United States Food and Drug Administration (FDA) has recently approved the marketing of several peptide-based radiopharmaceuticals, sparking a global trend of research in this area and propelling nuclear medicine into the precision theranostic era. This has created a new wave of technological competition in the field of nuclear medicine. It is the responsibility of Chinese scientists in the radiopharmaceutical field to capitalize on this opportunity, leverage the momentum, and strengthen their independent innovation capability in order to stay ahead in the future global nuclear science and technology competition. This review provides an overview of the remarkable progress made in the research, development, and translation of global peptide-based radiopharmaceuticals. It examines the advantages of peptide-based radiopharmaceuticals and outlines the current hot targets and progress in drug development in this field. Additionally, it proposes six opportunities for China to overtake others in the field of peptide-based radiopharmaceuticals and achieve technological self-reliance, based on interdisciplinary collaboration and independent innovation. Lastly, the future prospect of peptide-based radiopharmaceuticals is discussed.

radiopharmaceutical  /  peptide targeting ligand  /  peptide radiopharmaceutical  /  medical isotope  /  nuclear imaging  /  theranostics
Xue-yao CHEN, Bo-yang ZHANG, Kuan HU, Rui WANG. Global progress in peptide radiopharmaceutical research and China's opportunities[J]. Acta Pharmaceutica Sinica, 2023 , 58 (12) : 3477 -3489 . DOI: 10.16438/j.0513-4870.2023-1193
Year 2023 volume 58 Issue 12
PDF
210
99
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2023-1193
  • Receive Date:2023-10-23
  • Online Date:2025-11-21
  • Published:2023-12-12
Article Data
Affiliations
History
  • Received:2023-10-23
  • Revised:2023-11-01
Funding
Affiliations
    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-1193
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT